EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing Escherichia coli in Pregnant Cows

Roberto M Vidal iD, David A Montero iD, Felipe Del Canto, Juan C Salazar iD, Carolina Arellano, Alhejandra Alvarez, Nora L Padola, Hernán Moscuzza, Analía Etcheverría, Daniel Fernández, Victoria Velez, Mauro García und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Roberto M Vidal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile. Hauptthemen laut MEDLINE: Escherichia coli Infections, Hemolytic-Uremic Syndrome, Shiga-Toxigenic Escherichia coli, Vaccines, Subunit. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Fomento al Desarrollo Científico y Tecnológico, National FONDEF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shiga toxin-producing Escherichia coli (STEC) is a zoonotic pathogen that causes gastroenteritis and Hemolytic Uremic Syndrome. Cattle are the main animal reservoir, excreting the bacteria in their feces and contaminating the environment. In addition, meat can be contaminated by releasing the intestinal content during slaughtering. Here, we evaluated the safety and immunogenicity of a vaccine candidate against STEC that was formulated with two chimeric proteins (Chi1 and Chi2), which contain epitopes of the OmpT, Cah and Hes proteins. Thirty pregnant cows in their third trimester of gestation were included and distributed into six groups (n = 5 per group): four groups were administered intramuscularly with three doses of the formulation containing 40 µg or 100 µg of each protein plus the Quil-A or Montanide™ Gel adjuvants, while two control groups were administered with placebos. No local or systemic adverse effects were observed during the study, and hematological parameters and values of blood biochemical indicators were similar among all groups. Furthermore, all vaccine formulations triggered systemic anti-Chi1/Chi2 IgG antibody levels that were significantly higher than the control groups. However, specific IgA levels were generally low and without significant differences among groups. Notably, anti-Chi1/Chi2 IgG antibody levels in the serum of newborn calves fed with colostrum from their immunized dams were significantly higher compared to newborn calves fed with colostrum from control cows, suggesting a passive immunization through colostrum. These results demonstrate that this vaccine is safe and immunogenic when applied to pregnant cows during the third trimester of gestation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coli InfectionsHemolytic-Uremic SyndromeShiga-Toxigenic Escherichia coliVaccines, SubunitAnimalsCattleFemalePregnancyImmunization, PassiveImmunoglobulin G

Stichwörter der Autor:innen

Shiga toxin-producing Escherichia coli (STEC)cattle immunizationchimeric subunit vaccine

Substanzen

Immunoglobulin GVaccines, Subunit

Autor:innen und Institutionen

  • Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
  • Instituto Milenio de Inmunología e Inmunoterapia, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
  • Programa de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
  • Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción 4070386, Chile.
  • Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil 7000, Argentina.
  • Centro de Investigación Veterinaria de Tandil (CIVETAN), Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil 7000, Argentina.

ORCID-Profile: Roberto M Vidal, David A Montero, Juan C Salazar

Förderung

  • Fondo de Fomento al Desarrollo Científico y Tecnológico
  • National FONDEF

Zitieren

APA

Vidal, R. M., Montero, D. A., Del Canto, F., Salazar, J. C., Arellano, C., Alvarez, A., Padola, N. L., Moscuzza, H., Etcheverría, A., Fernández, D., Velez, V., García, M., Colello, R., Sanz, M., & Oñate, A. (2023). Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing Escherichia coli in Pregnant Cows. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032771

Vancouver

Vidal RM, Montero DA, Del Canto F, Salazar JC, Arellano C, Alvarez A, et al. Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing Escherichia coli in Pregnant Cows. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032771

BibTeX
@article{Vidal2023,
  author = {Vidal, Roberto M and Montero, David A and Del Canto, Felipe and Salazar, Juan C and Arellano, Carolina and Alvarez, Alhejandra and Padola, Nora L and Moscuzza, Hernán and Etcheverría, Analía and Fernández, Daniel and Velez, Victoria and García, Mauro and Colello, Rocío and Sanz, Marcelo and Oñate, Angel},
  title = {Safety and Immunogenicity of a Chimeric Subunit Vaccine against Shiga Toxin-Producing Escherichia coli in Pregnant Cows},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032771}
}
Kostenlos starten →